FIELD: medicine.
SUBSTANCE: invention relates to medicine, particularly to ophthalmology. That is ensured by the integrated treatment involving the single macular exposure to a sublimit micro-pulse infrared laser light. That is combined with the ozone therapy using drug preparations with underlying mixed gas agitation. That is followed by an antioxidant therapy consisting of local instillations of emixipin and oral administration of complivit oftalmo.
EFFECT: method enables the therapy of predisciform age-related macular degeneration at the stage of confluent drusens, preventing the development of the disease and improving the visual acuity.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF LASER TREATMENT OF FUSED DRUSEN IN CASE OF AGE-RELATED MACULAR DEGENERATION | 2011 |
|
RU2472476C1 |
| METHOD FOR COMPLEX TREATMENT OF HEMODYNAMIC DISORDERS OF BULBAR CONJUNCTIVA OF PATIENTS WITH COVID-19 ASSOCIATED PNEUMONIA | 2021 |
|
RU2747408C1 |
| METHOD OF TREATMENT OF MACULAR FOR AGE-RELATED MACULAR DEGENERATION | 2017 |
|
RU2647142C1 |
| METHOD OF COMBINED LASER TREATMENT OF DRUSENOID SEPARATION OF RETINAL PIGMENT EPITHELIUM | 2019 |
|
RU2727035C1 |
| METHOD OF TREATING AGE-RELATED MACULAR DYSTROPHY | 2013 |
|
RU2534806C1 |
| METHOD OF CENTRAL SEROUS CHORIORETINOPATHY TREATMENT | 2022 |
|
RU2797276C1 |
| METHOD OF LASER TREATMENT OF MACULAR DRUSES IN AGE-RELATED MACULAR DEGENERATION | 2011 |
|
RU2476193C1 |
| METHOD OF LASER TREATMENT OF MACULAR EDEMA ASSOCIATED WITH CHRONIC ISCHEMIC RETINOPATHY | 2020 |
|
RU2727870C1 |
| PROGNOSIS METHOD FOR EFFECTIVENESS OF SUBTHRESHOLD MICRO-PULSE LASER TREATMENT OF COMPLICATED FORM OF SCLEROGENIC MACULAR DEGENERATION | 2021 |
|
RU2758661C1 |
| METHOD FOR NAVIGATION LASER TREATMENT OF MACULAR DRUSES IN AGE-RELATED MACULAR DEGENERATION | 2021 |
|
RU2786553C1 |
